IMMUNE CELL ENGINEERING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Immune Cell Engineering Market, By Cell Type (T Cells, NK Cells, Dendritic Cells, Tumor Cells, Stem Cells, Others), By Product (Consumables, Instruments, Software), By Disease Indication (Cardiovascular Diseases, Respiratory Diseases, Infectious Diseases, Cancer, Neurological Diseases, Others), By Application (Research Applications, Cell Therapy & Regenerative Medicine, Others), By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Academic & Research Institutes, Cell Banks, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

North America is expected to be the largest market for global immune cell engineering market during the forecast period, accounting for over 38.5% of the market share in 2023. The growth of the market in North America is attributed to the high adoption of immunotherapies, presence of leading biopharma companies, and increasing cancer research.
The Europe market is expected to be the second-largest market for immune cell engineering market, accounting for over 32.1% of the market share in 2023. The growth of the market in is attributed to the rising investments by government bodies to support cell-based research.

The Asia Pacific market is expected to be the fastest-growing market for immune cell engineering market, with a CAGR of over 22.6% during the forecast period. The growth of the market in Asia Pacific is attributed to an increasing focus on developing cell therapies and government funding to support biotechnology sector.